Viewing StudyNCT05020249



Ignite Creation Date: 2024-05-06 @ 4:33 PM
Last Modification Date: 2024-10-26 @ 2:12 PM
Study NCT ID: NCT05020249
Status: COMPLETED
Last Update Posted: 2024-03-22
First Post: 2021-08-20

Brief Title: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-09-27
Start Date Type: ACTUAL
Primary Completion Date: 2022-09-05
Primary Completion Date Type: ACTUAL
Completion Date: 2022-09-06
Completion Date Type: ACTUAL
First Submit Date: 2021-08-20
First Submit QC Date: August 20 2021
Study First Post Date: 2021-08-25
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2024-03-22
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-21
Last Update Post Date: 2024-03-22
Last Update Post Date Type: ACTUAL